01 April:Registrations and abstract submission opens 15 May:Early bird registration deadline & abstract submission deadline 1 October:Abstract publication (end of embargo) Sponsors Platinum 1/6 Gold 1/7 Silver 1/55 Bronze 1/2
参考资料: 1.https://www.biospace.com/article/releases/rocket-pharmaceuticals-announces-presentations-highlighting-lentiviral-gene-therapies-at-the-29th-annual-congress-of-the-european-society-of-gene-and-cell-therapy-esgct-/ 2.https...
ESGCT 2022 - 29th Annual Congress of the European Society of Gene and Cell Therapy Date: October 11-14, 2022 Venue: Edinburgh, Scotland, UK ESGCT organises an Annual Congress, which brings together scientists working in the fields of gene and cell therapy from throughout Europe and beyond. ...
BOSTON and LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) --Orchard Therapeutics(Nasdaq: ORTX), a global gene therapy leader, today announced a range of interim clinical outcomes, in addition to the previously reported neurological and...
摘要可在ESGCT网站上查阅:https://www.esgctcongress.com/ 关于马萨诸塞州立大学医学院红瑞(Horae)基因治疗中心 红瑞(Horae)基因治疗中心致力于开发尚未治癒的罕见遗传性疾病的治疗疗法。中心利用最先进的技术编辑产生致病蛋白质的突变基因,或者在突变导致非功能性蛋白质的情况下引入基因的健康拷贝。 Horae基因治疗中心...
1)The 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) that will take place on October 24-27, 2023 in Brussels, (Belgium): “Gene therapy for LGMDR9: preliminary results of a dose-escalation study” • ...